Upcoming events on PHARMING GROUP

05/11/2026

Earnings release - Q3 2026

Past events on PHARMING GROUP

30/07/2026

Earnings presentation

12:30
30/07/2026

Earnings release - Q2 2026

28/05/2026

Annual General Meeting

13:00
28/05/2026

Présentation aux Actionnaires / Analystes

13:00
07/05/2026

Earnings presentation

12:30
07/05/2026

Earnings release - Q1 2026

12/03/2026

Earnings presentation

12:30
12/03/2026

Earnings release - Q4 2025

03/02/2026

Analyst/Investor Day

15:00
06/11/2025

Earnings release - Q3 2025

06/11/2025

Earnings presentation

12:30

Annual results

Fiscal PeriodDecember 2023 2024 2025 2026 2027 2028
Net sales
Million USD
Released
Forecast
Spread
245
245
0.07%
297
286
3.74%
376
376
0.04%

383


425


426

EBITDA
Million USD
Released
Forecast
Spread
10,5
2,65
297.66%
7,45
4,25
75.27%
37,1
41,5
-10.8%

48,7


76,5


0,00

EBIT
Million USD
Released
Forecast
Spread
-5,39
-8,15
33.87%
-8,62
-10,00
13.75%
25,8
34,1
-24.12%

16,7


29,4


33,3

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-12,0
-5,53
-117.2%
-8,51
-10,2
16.71%
12,8
18,8
-31.51%

24,5


35,2


35,1

Net income
Million USD
Released
Forecast
Spread
-10,1
-4,03
-151.07%
-11,0
-10,9
-1.1%
2,85
4,55
-37.39%

21,0


29,6


31,7

EPS
USD
Released
Forecast
Spread
-0,02
-0,01
-50%
-0,02
-0,02
7.89%
0,00
0,00
66.67%

0,04


0,03


0,02

Announcement Date14/03/2413/03/2512/03/26-

Quarterly results

Fiscal PeriodJune 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 S1 2026 Q3 2026 Q4 2027 Q1 2027 Q2 2027 Q3 2027 Q4
Net sales
Million USD
Released
Forecast
Spread
92,7
81,3
14.09%
79,1
64,0
23.58%
93,2
82,6
12.82%
97,3
91,7
6.08%
107
105
1.12%
72,4
92,1
-21.31%
90,2
99,5
-9.35%
163
183
-11.24%

104


115


76,0


94,5


104


118

EBIT
Million USD
Released
Forecast
Spread
6,70
5,48
22.23%
-7,04
-18,1
61.08%
10,8
-0,60
1908.17%
15,8
5,80
172.81%
6,20
12,9
-51.75%
-4,91
4,00
-222.78%
1,31
6,90
-80.96%




10,5


15,1


-10,2


-2,30


0,30


10,2

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
6,60
5,53
19.28%
-11,8
-13,9
14.89%
7,08
-6,60
207.26%
12,8
5,00
155.16%
4,80
10,6
-54.72%
-4,75
3,83
-223.99%
3,04
15,6
-80.46%
-1,71
19,3
-108.88%

12,3


16,4


-9,20


-1,30


1,30


11,2

Net income
Million USD
Released
Forecast
Spread
3,70
3,83
-3.48%
-14,7
-14,1
-4.39%
4,69
-8,20
157.24%
7,55
3,35
125.31%
5,33
6,67
-20.08%
-5,21
2,30
-326.65%
1,64
14,3
-88.55%
-3,58
18,1
-119.75%

11,9


15,7


-6,90


-1,00


0,90


8,40

EPS
USD
Released
Forecast
Spread
0,01
0,00
-









0,01
0,00
-










0,01


0,02


-0,01


0,00


0,00


0,01

Announcement Date13/03/2508/05/2531/07/2506/11/2512/03/2607/05/2630/07/2630/07/26------
31/08/2026

Earnings release - Q2 2026

31/08/2026

Significant Split/Dividend

05:00
31/08/2026

Earnings release - Q2 2026

31/08/2026

Earnings release - Q2 2026

31/08/2026

Board of Directors Meeting

31/08/2026

Significant Split/Dividend

05:00
31/08/2026

Ex-dividend date - 2.56532 TWD

05:00
31/08/2026

Earnings release - Q2 2026

31/08/2026

Extraordinary General Meeting

31/08/2026

Présentation aux Actionnaires / Analystes

04:00

Past sector events for PHARMING GROUP

29/08/2026

Earnings release - Q2 2026

29/08/2026

Earnings release - Q2 2026

29/08/2026

Earnings release - Q2 2026

29/08/2026

Earnings release - Q2 2026

29/08/2026

Earnings release - Q2 2026

29/08/2026

Earnings release - Q2 2026

29/08/2026

Earnings release - Q2 2026

29/08/2026

Earnings release - Q2 2026

29/08/2026

Earnings release - Q2 2026

29/08/2026

Earnings release - Q2 2026